Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT02958202 · TERMINATED
Trial details
- NCT number
- NCT02958202
- Sponsor
- BioMarin Pharmaceutical
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2016-09-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.